About UsMembershipAccomplishmentsMeetingsSupportNewsroom

iSBTc News

Society and Member News   |   E-newsletters   |   Press Releases   |   For the Media

Press Release

Contact:

Tara Withington, CAE (iSBTc Executive Director)
International Society for Biological Therapy of Cancer
555 E. Wells St., Suite 1100, Milwaukee, WI 53202
Phone: 414-271-2456 • Fax: 414-276-3349
Email: twithington@isbtc.org
Website: www.isbtc.org

NOTE: Members of the media are encouraged to attend the "Primer on Tumor Immunology and Biological Therapy of Cancer" free-of-charge by presenting their press credentials at the iSBTc registration desk.

For Immediate Release

CANCER LEADERS TO ADDRESS TUMOR IMMUNOLOGY AND BIOLOGICAL THERAPY

Milwaukee, WI --- The International Society for Biological Therapy of Cancer's "Primer on Tumor Immunology and Biological Therapy of Cancer" (Primer) will be held on Thursday, October 30, 2008 in San Diego, CA. Organized by Patrick Hwu, MD of MD Anderson Cancer Center and Kim A. Margolin, MD of the University of Washington, the 2008 Primer will feature an international slate of prominent researchers in the fields of cancer biologics and immunotherapy.

iSBTc's Primer provides a series of lectures that address the fields of tumor immunology and immunotherapy, moving from the most basic principles to the most advanced and cutting-edge research ideas. Audience members will learn central concepts and recent advances in biologic therapies including cancer vaccines, vaccine adjuvants, host-tumor interactions and the role of the innate and adaptive immune systems in tumor immunology and therapy.

"iSBTc has long been an epicenter for new data presentations," said Dr. Margolin, Primer Organizer. "It is a purposeful as well as serendipitous meeting among investigators interested in the field of cancer immunology and all the networked fields, including angiogenesis, inflammation and autoimmunity."

This year's Primer faculty includes:

  • James P. Allison, PhD; Memorial Sloan-Kettering Cancer Center
  • David A. Cheresh, PhD; University of California, San Diego
  • Phillip D. Greenberg, MD; Fred Hutchison Cancer Research Center and University of Washington
  • Michael D. Kalos, PhD; University of Washington
  • William J. Murphy, PhD; University of Nevada School of Medicine
  • Lee M. Nadler, MD; Dana-Farber Cancer Institute
  • A. Karolina Palucka, MD, PhD; Baylor Institute for Immunology Research
  • Shimon Sakaguchi, MD, PhD; Kyoto Univeristy, Japan
  • Mario Sznol, MD; Yale University School of Medicine
  • Walter J. Urba, MD, PhD; Earle A. Chiles Research Institute

Details and a complete schedule for the Primer can be found at the Society's website at www.isbtc.org. Registration will be available onsite at the Westin Gaslamp Quarter Hotel in San Diego, CA.

Founded in 1984, the International Society for Biological Therapy of Cancer is a not-for-profit organization of clinicians, researchers, students, post-doctoral fellows, and allied health professionals dedicated to improving cancer patient outcomes by advancing the development and application of biological therapy through interaction, innovation and leadership.

###